{"id":"W3121895660","doi":"10.1200/jco.2021.39.3_suppl.tps145","title":"BOLD-100-001 (TRIO039): A phase Ib dose-escalation study of BOLD-100 in combination with FOLFOX chemotherapy in patients with advanced gastrointestinal solid tumors.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Translational Research in Oncology; Juravinski Cancer Centre; Princess Margaret Cancer Centre; Ottawa Hospital; McGill University; McMaster University; Alberta Health Services","funders":"","keywords":"FOLFOX; Medicine; Tolerability; Oncology; Internal medicine; Chemotherapy; Colorectal cancer; Phases of clinical research; Response Evaluation Criteria in Solid Tumors; Combination therapy; Cancer; Oxaliplatin; Gastroenterology; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007337952,0.0001482569,0.0007523946,0.0001264867,0.00002233428,0.000008387505,0.0001379513,0.000107832,0.0000292329],"category_scores_gemma":[0.000477261,0.0001101127,0.00009493995,0.0002522624,0.00009556642,0.00002178826,0.0000441726,0.0003872236,7.092643e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001184127,"about_ca_system_score_gemma":0.001026361,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001091492,"about_ca_topic_score_gemma":0.002162818,"domain_scores_codex":[0.997421,0.0003775903,0.00131144,0.0002729376,0.0003677966,0.0002492781],"domain_scores_gemma":[0.997853,0.000152848,0.001046075,0.0001871222,0.0006063699,0.0001545937],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03389453,0.06530777,0.8433539,0.00001674787,0.0001878097,0.0003773256,0.00007426622,0.0002308061,0.002526589,0.000003177719,0.00008573296,0.05394135],"study_design_scores_gemma":[0.09618851,0.1586159,0.7420712,0.0001251971,0.00003613227,0.00005543766,0.0001673493,0.00004541366,0.002267561,0.00003215575,0.0002902682,0.000104839],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9989947,0.00008103799,0.0001060524,0.0002095751,0.00006665466,0.0004081193,0.000006759036,0.000001738004,0.0001253646],"genre_scores_gemma":[0.9987401,0.00008186363,0.0008843453,0.00009288455,0.00008020741,0.00001451027,0.00004637654,0.00001715035,0.00004251403],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1012827,"threshold_uncertainty_score":0.4490264,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03731174198347995,"score_gpt":0.4351419497730816,"score_spread":0.3978302077896017,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}